ENTEROME

L'entreprise ENTEROME est spécialisée en recherches, études et analyses spécialisées.

Isabelle de Cremoux has served as a member of our board of directors since 2008. From June 2017 to June 2018, Ms. de Cremoux served as representative of Seventure Partners, the legal entity that held this board seat during that period. Since 2001, Ms. de Cremoux has served as Chief Executive Officer and Managing Partner of Seventure Partners, where she established and leads the life sciences team. Previously, Ms. de Cremoux worked at Arthur Andersen LLP from 1991 to 1993. From 1998 to 2001, Ms. de Cremoux served as Deputy Director of Business Development at Laboratoire Fournier S.A.S. / Abbott Laboratories. From 1993 to 1998, Ms. de Cremoux worked at Pfizer France and Pfizer Europe, where she held various positions within management, clinical research and business development. Ms. de Cremoux holds a degree in Engineering from l’Ecole Centrale Paris. Our board of directors believes that Ms. de Cremoux’s experience in the pharmaceutical industry, including management and executive positions, provides her with the qualifications and skills to serve as a director.